Kairos Pharma, LTD. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Kairos Pharma, LTD. quarterly Earnings Per Share, Basic history and growth rate from Q3 2023 to Q3 2024.
  • Kairos Pharma, LTD. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.1 USD/shares, a 233% decline year-over-year.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.